Bellevue Life Sciences Ac...

NASDAQ: BLAC · Real-Time Price · USD
3.01
-3.72 (-55.27%)
At close: Feb 14, 2025, 3:53 PM

Bellevue Life Sciences Acquisition Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
66.14K 15.42K 124.5K 4.76K
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
1.85M n/a n/a n/a
Other Long-Term Assets
n/a 36.61M 1.1M 700.33K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
389.26K n/a n/a n/a
Total Current Assets
455.4K 22.63K 124.5K 4.76K
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.85M 36.61M 1.1M 700.33K
Total Assets
2.3M 36.63M 1.23M 705.09K
Account Payables
n/a 1.08M 34K 2.85K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
1.76M n/a 1.2M 400K
Other Current Liabilities
4.6M 1.51M n/a n/a
Total Current Liabilities
6.72M 2.04M 1.26M 707.21K
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
2.07M 2.07M n/a n/a
Total Long-Term Liabilities
2.07M 2.07M 1.23M n/a
Total Liabilities
8.79M 4.11M 1.26M 707.21K
Total Debt
1.76M n/a 1.2M 400K
Common Stock
1.85M 36.43M 173.00 173.00
Retained Earnings
-8.33M -3.91M -62.51K -27.12K
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
-6.49M 32.52M -37.51K -2.12K
Total Investments
n/a 36.61M n/a n/a